Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

The new microneedle treatment could be a more effective and convenient option for hair loss.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Using a dexpanthenol ointment after micro-needling speeds up skin healing without affecting benefits.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Dendrobium candidum polysaccharides promote hair growth.

Optimized microneedles promote hair regrowth better than minoxidil without safety risks.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

A new microneedle treatment can help regrow hair by improving lymphatic function and metabolism.

Low-dose oral and topical minoxidil are recommended for managing hair loss in transplant patients, with specific dosing and timing guidelines.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

A new microneedle patch effectively and safely treats alopecia areata.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A new microneedle system effectively treats hair loss by delivering drugs directly to hair follicles.

The microneedle system shows promise for non-invasive brain drug delivery.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.